NXTSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Nexentis Technologies Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.64−0.00 (-0.73%)
Close on Oct 19, 2026
- Market cap
- $522.65K
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Apr 8, 2026 | 1-for-7 reverse | Earlier per-share figures multiplied by 7 |
| Sep 22, 2025 | 1-for-35 reverse | Earlier per-share figures multiplied by 35 |
| Nov 14, 2023(first seen in filings) | 1-for-6.67 reverse | Earlier per-share figures multiplied by 6.6667 |
| Oct 6, 2023 | 1-for-7 reverse | Earlier per-share figures multiplied by 7 |
| Mar 29, 2021(first seen in filings) | 1-for-7 reverse | Earlier per-share figures multiplied by 7 |
| Feb 25, 2021 | 1-for-7 reverse | Earlier per-share figures multiplied by 7 |
| Jun 13, 2019 | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |